Group 1: Current Situation of Allergic Diseases - The global prevalence of allergic diseases is on the rise, with allergic rhinitis being a significant health concern affecting over 500 million people worldwide, representing 10% to 40% of the population [1][5] - In China, the number of self-reported allergic rhinitis cases increased by nearly 100 million from 2005 to 2011, with a notable rise in prevalence among children, reaching 19.75% from 2012 to 2021 [1][5] Group 2: Causes and Contributing Factors - The high incidence of allergic diseases is attributed to multiple factors, including environmental pollution, lifestyle changes, and urbanization, which have collectively exacerbated the situation [2][5] - Increased indoor time and exposure to allergens such as dust mites and pets, along with dietary shifts towards fast and processed foods, are significant contributors to the growing allergic population [5][6] Group 3: Awareness and Education Gaps - There is a lack of awareness among the general public regarding the symptoms and diagnosis of allergic diseases, leading to misinterpretation of allergic rhinitis as common colds [6][7] - Medical professionals also face challenges due to insufficient education on allergic diseases, resulting in difficulties in recognizing symptoms and assessing their impact on patients' quality of life [7][8] Group 4: Treatment and Management Recommendations - Effective management of allergic rhinitis in children is crucial, as it can impact their ability to learn and participate in activities, potentially leading to complications like asthma [8][9] - Recommendations for treatment include the use of second-generation antihistamines for mild to moderate cases and nasal corticosteroids for more severe cases, with an emphasis on early intervention and proper medication adherence [9][10] Group 5: Global Initiatives and Collaboration - The World Allergy Organization (WAO) is actively working to improve the management of allergic diseases through education, establishing "centers of excellence," and developing global guidelines tailored to local contexts [13][15] - WAO's initiatives include training programs for healthcare providers in regions with a shortage of allergy specialists, aiming to enhance the quality of care and public awareness [13][16] Group 6: Future Directions and Digital Tools - There is a focus on expanding the network of certified allergy centers in China to improve public health responses to allergic diseases and enhance collaboration among healthcare providers [15][18] - The use of digital tools in China for diagnosis, patient follow-up, and education is recognized as a significant advantage that can be leveraged to improve allergic disease management globally [18]

Group 1: Current Situation of Allergic Diseases - The global prevalence of allergic diseases, particularly allergic rhinitis, is on the rise, affecting over 500 million people worldwide, which is about 10% to 40% of the population [1][2] - In China, the number of individuals reporting allergic rhinitis has increased by nearly 100 million from 2005 to 2011, with a significant rise in prevalence among children from 4.81% (2001-2011) to 19.75% (2012-2021) [1][2] Group 2: Causes and Challenges - The high incidence of allergic diseases is attributed to multiple factors, including environmental pollution, lifestyle changes, and urbanization, which have collectively contributed to the increasing prevalence [2][3] - Allergic rhinitis is a common chronic condition across all age groups, often coexisting with other allergic conditions such as asthma and atopic dermatitis, leading to a significant burden on healthcare systems [3][4] Group 3: Awareness and Education - There is a lack of awareness among the general public regarding the symptoms and diagnosis of allergic diseases, leading to misdiagnosis and inadequate treatment [5][6] - Medical professionals also face challenges due to insufficient education on allergic diseases, resulting in difficulties in recognizing symptoms and assessing their impact on patients' quality of life [6] Group 4: Treatment Recommendations - Education is crucial for managing allergic rhinitis, emphasizing the importance of recognizing chronic symptoms and avoiding allergens [7][8] - For mild to moderate cases in children, second-generation antihistamines are recommended, while intranasal corticosteroids may be used for more severe cases [7][8] Group 5: Global Initiatives and Collaboration - The World Allergy Organization (WAO) is actively working to improve the diagnosis and treatment of allergic rhinitis through educational programs and the establishment of "Excellence Centers" worldwide, including four in China [12][14] - WAO aims to enhance collaboration with local medical communities to improve healthcare services and raise awareness about allergic diseases [14][16] Group 6: Future Directions - There is a focus on expanding the network of certified allergy centers in China to improve treatment standards and address the public health impact of allergic diseases [16] - The use of digital tools in China for diagnosis, patient follow-up, and education is recognized as a significant advantage that can be leveraged for better management of allergic conditions [17]